Concentrix Statistics
Total Valuation
Concentrix has a market cap or net worth of $1.55 billion. The enterprise value is $7.06 billion.
Important Dates
The last earnings date was Tuesday, March 24, 2026, before market open.
| Earnings Date | Mar 24, 2026 |
| Ex-Dividend Date | Apr 24, 2026 |
Share Statistics
Concentrix has 61.00 million shares outstanding. The number of shares has decreased by -3.59% in one year.
| Current Share Class | 61.00M |
| Shares Outstanding | 61.00M |
| Shares Change (YoY) | -3.59% |
| Shares Change (QoQ) | -1.24% |
| Owned by Insiders (%) | 3.02% |
| Owned by Institutions (%) | 85.99% |
| Float | 42.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.10 |
| PS Ratio | 0.16 |
| Forward PS | 0.15 |
| PB Ratio | 0.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.29 |
| P/OCF Ratio | 2.21 |
| PEG Ratio | 0.28 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.74, with an EV/FCF ratio of 14.58.
| EV / Earnings | n/a |
| EV / Sales | 0.71 |
| EV / EBITDA | 5.74 |
| EV / EBIT | 12.35 |
| EV / FCF | 14.58 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 2.04.
| Current Ratio | 1.18 |
| Quick Ratio | 0.88 |
| Debt / Equity | 2.04 |
| Debt / EBITDA | 3.38 |
| Debt / FCF | 11.74 |
| Interest Coverage | 1.58 |
Financial Efficiency
Return on equity (ROE) is -38.92% and return on invested capital (ROIC) is 7.06%.
| Return on Equity (ROE) | -38.92% |
| Return on Assets (ROA) | 3.17% |
| Return on Invested Capital (ROIC) | 7.06% |
| Return on Capital Employed (ROCE) | 7.06% |
| Weighted Average Cost of Capital (WACC) | 5.45% |
| Revenue Per Employee | $21,877 |
| Profits Per Employee | -$2,922 |
| Employee Count | 455,000 |
| Asset Turnover | 0.88 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Concentrix has paid $73.31 million in taxes.
| Income Tax | 73.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.14% in the last 52 weeks. The beta is 0.50, so Concentrix's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -48.14% |
| 50-Day Moving Average | 30.04 |
| 200-Day Moving Average | 41.36 |
| Relative Strength Index (RSI) | 39.07 |
| Average Volume (20 Days) | 1,325,334 |
Short Selling Information
The latest short interest is 10.74 million, so 17.61% of the outstanding shares have been sold short.
| Short Interest | 10.74M |
| Short Previous Month | 11.88M |
| Short % of Shares Out | 17.61% |
| Short % of Float | 25.34% |
| Short Ratio (days to cover) | 5.37 |
Income Statement
In the last 12 months, Concentrix had revenue of $9.95 billion and -$1.33 billion in losses. Loss per share was -$21.33.
| Revenue | 9.95B |
| Gross Profit | 3.43B |
| Operating Income | 572.10M |
| Pretax Income | -1.25B |
| Net Income | -1.33B |
| EBITDA | 1.23B |
| EBIT | 572.10M |
| Loss Per Share | -$21.33 |
Full Income StatementBalance Sheet
The company has $222.70 million in cash and $5.69 billion in debt, with a net cash position of -$5.47 billion or -$89.61 per share.
| Cash & Cash Equivalents | 222.70M |
| Total Debt | 5.69B |
| Net Cash | -5.47B |
| Net Cash Per Share | -$89.61 |
| Equity (Book Value) | 2.79B |
| Book Value Per Share | 45.85 |
| Working Capital | 465.88M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $722.34 million and capital expenditures -$237.78 million, giving a free cash flow of $484.56 million.
| Operating Cash Flow | 722.34M |
| Capital Expenditures | -237.78M |
| Depreciation & Amortization | 659.09M |
| Net Borrowing | -263.11M |
| Free Cash Flow | 484.56M |
| FCF Per Share | $7.94 |
Full Cash Flow StatementMargins
Gross margin is 34.45%, with operating and profit margins of 5.75% and -13.34%.
| Gross Margin | 34.45% |
| Operating Margin | 5.75% |
| Pretax Margin | -12.60% |
| Profit Margin | -13.34% |
| EBITDA Margin | 12.37% |
| EBIT Margin | 5.75% |
| FCF Margin | 4.87% |
Dividends & Yields
This stock pays an annual dividend of $1.44, which amounts to a dividend yield of 5.65%.
| Dividend Per Share | $1.44 |
| Dividend Yield | 5.65% |
| Dividend Growth (YoY) | 8.61% |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | 3.59% |
| Shareholder Yield | 9.09% |
| Earnings Yield | -83.27% |
| FCF Yield | 30.35% |
Dividend DetailsAnalyst Forecast
The average price target for Concentrix is $54.80, which is 115.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $54.80 |
| Price Target Difference | 115.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Concentrix has an Altman Z-Score of 1.36 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.36 |
| Piotroski F-Score | 5 |
